Cagrilintide is a long-acting amylin analog peptide being developed for weight loss and obesity treatment. It is designed to mimic amylin, a hormone that helps regulate appetite and blood sugar.
What Cagrilintide does
- Appetite Suppression – Amylin is released from the pancreas alongside insulin after meals
- Signals fullness to the brain (especially the hypothalamus)
- Slows gastric emptying
- Reduces food intake
Cagrilintide mimics these effects but lasts much longer in the body.
Potential benefits
- Substantial weight loss
- Reduced hunger
- Improved metabolic markers
- Potential improvement in type 2 diabetes
Disclaimer: This is for research and informational purposes only. Our products are not for human consumption. For medical advice or diagnosis, consult a professional.
